Email:

ploehrer@iu.edu

Departments:

Global Health

Degrees:

MD, Rush Medical College

BS, Mechanical Engineering, Purdue University

Biography

Patrick J. Loehrer, Sr, MD, is the HH Gregg Professor of Oncology and Distinguished Professor of Indiana University where he serves as the Director of the Indiana University Melvin and Bren Simon Cancer Center and Associate Dean for Cancer Research. He has been an active clinical researcher and specialist in the treatment of a variety of cancers including testis, bladder, colon, pancreas and, most notably, thymic malignancies. His research on the drug, ifosfamide, led to its approval by the FDA. His research related to thymic cancers has been recognized with the Exceptional Service Award of the Foundation for Thymic Research.

Dr. Loehrer received his undergraduate degree in Mechanical Engineering from Purdue University in 1975 and his medical degree from Rush Medical College in 1978. He completed his internship and residency at Rush Presbyterian St. Luke's Medical Center and a fellowship in Medical Oncology at Indiana University. In 1983, he joined the faculty of the Indiana University School of Medicine, the largest Medical School in the country. Since 2009, Dr. Loehrer has been director of the IU Simon Cancer Center, an NCI-designated Cancer Center.

Dr. Loehrer was the founding chair of the Hoosier Oncology Group (now Hoosier Cancer Research Network) for two decades, which has enrolled over 5,000 patients and conducted trials in 20 countries around the world. Dr. Loehrer has served on the boards of the ECOG Foundation, the American Society of Clinical Oncology, and the American Board of Internal Medicine. He serves on the Advisory Committee for the Indiana University Center for Global Health. Dr. Loehrer is also the founding director of the Academic Model for Providing Access to Healthcare (AMPATH)-Oncology Program for over the past decade, which now sees over 8,000 cancer patients a year and screens over 1,500 women for cervical and breast cancers a month in western Kenya. He has been co-PI for an U54-grant that focuses on longitudinal HPV screening of women in East Africa.

Dr. Loehrer has received numerous awards including the Special Recognition Award and the inaugural, Allen S. Lichter Visionary Leader Award from the American Society of Clinical Oncology, the Bicentennial Medal from Indiana University. From Purdue University, he has received the Outstanding Mechanical Engineering Award and the Distinguished Engineering Alumni Award. He has served on the Board of Directors for the American Association of Cancer Institutes and served as the annual meeting Program Committee Chair in 2015. He currently serves as Chair of the National Cancer Institute Clinical Trials Advisory Committee.